Parkinson's Trial NCT06892717
Improve walking reduce caregiver burden
- Trial ID
- NCT06892717
- Official Title
- Caregiver Burden and Associated Factors in Parkinson's Disease
- Goal
- Improve walking reduce caregiver burden
- Status
- RECRUITING
- Sponsor
- Beylikduzu State Hospital
- Study Type
- OBSERVATIONAL
- Enrollment
- 43 participants
- Conditions
- Parkinson Disease
- Interventions
Summary For Families
The goal is to measure caregiver burden and identify which patient and caregiver factors, like Parkinson's severity and daily care needs, are linked to higher stress, fatigue, or reduced quality of life for unpaid family caregivers. The study is observational, collecting information from patients and their informal caregivers using interviews, questionnaires, and routine clinical data to quantify burden and relate it to disease stage and care requirements. They are looking for people 40 to 80 years old with Parkinson's at Hoehn and Yahr stage 2 to 5 who need help with daily activities and who have an unpaid caregiver fluent in Turkish; people with other neurodegenerative diseases, active cancer, severe heart failure, COPD, stroke-related limitations, or immobility for reasons other than Parkinson's are excluded.
Locations
- Beylikdüzü State Hospital, Istanbul, Beylikdüzü, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to measure caregiver burden and identify which patient and caregiver factors, like Parkinson's severity and daily care needs, are linked to higher stress, fatigue, or reduced quality of life for unpaid family caregivers. The study is observational, collecting information from patients and their informal caregivers using interviews, questionnaires, and routine clinical data to quantify burden and relate it to disease stage and care requirements. They are looking for people 40 to 80 years old with Parkinson's at Hoehn and Yahr stage 2 to 5 who need help with daily activities and who have an unpaid caregiver fluent in Turkish; people with other neurodegenerative diseases, active cancer, severe heart failure, COPD, stroke-related limitations, or immobility for reasons other than Parkinson's are excluded.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 2 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.